Subscribe

Receive updates about our latest products in your inbox

Register For Our Next Webinar

Back-to-School Immune Boosting

About Us

For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional

Search the Blog

  • There are no suggestions because the search field is empty.

Cranberry Extract & the Microbiota

iStock-1179720626Results of a small human clinical trial recently published in NPJ Biofilms and Microbiomes indicate that short-term use of cranberry extract has a bifidogenic effect and increases the abundance of butyrate-producing bacteria, the first study to report on cranberry-induced microbiome changes. This study was done both to characterize the specific polyphenols and oligosaccharides found within a specific cranberry extract, and to determine its effects on the microbiome (using 16 S rRNA sequencing) of 39 healthy volunteers after only 4 days of use.

The majority of the polyphenols in this cranberry extract were found to be flavan-3-ols (75% of total), with lesser amounts of anthocyanidins (5%), flavonols (13%), and phenolic acids (7%). Acid hydrolysis was used to break down larger oligosaccharides into simple carbohydrates, which included glucose, arabinose, xylose, and others (no detail was provided for the type of oligosaccharides found prior to hydrolysis, but arabinoxyloglucans plausibly account for the majority).

Among the 28 participants who provided fecal samples at baseline and after 4 days of use (1 capsule twice per day), the extract was shown to significantly increase species richness and decrease α-diversity. Specifically, it reduced the abundance of Bacteroides (including 5 Bacteroides species) while increasing the abundance of two species of Bifidobacterium (Bifidobacterium adolescentis and Bifidobacterium longum). Previous research in experimental models suggests that cranberry extract may also increase Akkermansia muciniphila levels, but overall no changes were reported in this study, potentially due to the short time frame or limitations in the accurate measurement of Akkermansia growth. Additionally, both plasma and fecal samples indicated trends toward favorable short-chain fatty acid production, including relative increases in butyrate and propionate (plasma only), and a reduction in acetate levels. Larger studies of longer duration would help to flush out these changes, and possibly identify variability in response to supplementation.

Submit your comment

Related Post

Oral Immunotherapy & the Microbiome

Results of a prospective and longitudinal study conducted among schoolchildren were recently published in Allergology In...

Learn more

Depression & the Microbiome

Results of a small pilot study published in May 2023 in Neuroscience explored connections between the gut microbiome and...

Learn more

Microbiome & COVID-19

In Genome Medicine, Harvard researchers recently published their analysis of metagenomic profiling of the gastrointestin...

Learn more